Obstructive sleep apnea is linked to an increased risk of long-term COVID. According to one study, persons with both sleep disturbance and COVID may benefit from clinical monitoring.
Specialized channel proteins are possible therapeutic targets for sleep apnea and similar abnormally slow breathing disorders in obese people, suggest Johns Hopkins Medicine researchers who did a study on mice.
Specialized channel proteins are possible therapeutic targets for sleep apnea and similar abnormally slow breathing disorders in obese people, suggest Johns Hopkins Medicine researchers who did a study on mice.